RxDoctor Payments Data

Stelian Serban, MD

Anesthesiology · Edison, NJNPI 1114902467

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,276 of the $2,759 with a category attached, or 82.5%. 13 manufacturers reported payments, led by Nevro Corp. at 41.4% of the total. 2025 is the largest year on record at $1,052, more than ten times the $63 reported in 2019. Among anesthesiology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,759in general payments, 2019–2025

Across 39 payments — averaging $70.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$1K
  • Abbott$624
  • Medtronic$223
  • Biotronik NRO, Inc.$212
  • Boston Scientific$175
  • SPR Therapeutics, Inc$145
  • plus $238 from 7 others

What the payments were for

  • Travel & lodging$48217%
  • Food & beverage$2,27683%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,759 in reported general payments places this provider in the 95th percentile of 1,430 anesthesiology providers in New Jersey.

See all anesthesiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$189,174
Medicare patients
250
Services billed
8,677

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl78$258,454
Diclofenac Sodium104$34,573
Oxycodone Hcl552$19,394
Xtampza ErOxycodone Myristate13$14,234
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen328$11,529
Fentanyl34$5,229
Lidocaine59$4,612
Naloxone Hcl56$3,664
Pregabalin137$3,563
Doxepin Hcl32$3,336
SymbicortBudesonide/Formoterol Fumarate14$3,207
Gabapentin270$2,896
Methadone Hcl109$2,396
Hydromorphone Hcl69$2,222
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine20$1,776

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$19$14,23413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,430 anesthesiology providers in New Jersey.

Other anesthesiology in Edison

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →